ArticleAnnals of surgical oncology2022

Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9.

Masaya Yamanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.